Royal Bank Of Canada Pardes Biosciences, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.21 - $2.22 $4,023 - $7,381	-3,325 Reduced 63.38%	1,921 $2,000
Q4 2022 Feb 14, 2023	BUY	$0.85 - $1.69 $4,103 - $8,159	4,828 Added 1155.02%	5,246 $8,000
Q3 2022 Nov 14, 2022	BUY	$2.14 - $3.7 $552 - $954	258 Added 161.25%	418 $1,000
Q2 2022 Aug 15, 2022	SELL	$2.84 - $8.57 $4,722 - $14,251	-1,663 Reduced 91.22%	160 $0
Q1 2022 May 16, 2022	BUY	$5.64 - $15.64 $10,281 - $28,511	1,823 New	1,823 $13,000

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.